CD8A and neoplasm: Coinciding with slower tumor growth, tumor-bearing mice receiving Sup-CD28WTCD8+ treated-P14 CD8+ Teff cells survived significantly longer than those receiving Sup-CD28KOCD8+-treated P14 CD8+ Teff cells (Fig. 1g).